8-K: Genvor Issues Series C Preferred Stock for Advisory Services

Genvor Incorporated has designated four shares of Series C Preferred Stock and issued one share to Brio Advisory Group LLC as part of an advisory agreement.

Summary

• Genvor Incorporated filed a certificate of designation for four shares of Series C Preferred Stock.
• Each share has a par value of $0.001 and carries one vote per share.
• The shares are convertible into common stock based on a $300,000 valuation, subject to listing status on national exchanges by April 14, 2027.
• One share of Series C Preferred Stock was issued to Brio Advisory Group LLC on May 8, 2026, pursuant to an advisory agreement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing; it reflects standard corporate housekeeping and the fulfillment of a previously disclosed advisory agreement.

Positives

• Secured advisory services through the issuance of equity rather than cash, preserving current liquidity.

Negatives

• Potential for future dilution of common shareholders upon the conversion of the Series C Preferred Stock.
• The conversion terms include a floor price of $1.00 per share if the company fails to list on a national exchange by April 2027, which could impact equity structure.

Risks

• The company faces a deadline of April 14, 2027, to list on a national securities exchange to avoid specific conversion price calculations.
• Potential dilution risk if the conversion price is set at the $1.00 floor in the event of non-listing.
• Limited liquidity and reliance on future capital market access.

Future Outlook

The company is working toward a potential listing on a national securities exchange by April 14, 2027, which would influence the conversion terms of the Series C Preferred Stock.

Management Comments

• The Board of Directors has authorized the issuance of preferred stock to facilitate corporate objectives and exchange for services.

Industry Context

StockSavvy.ai notes that small-cap companies frequently utilize specialized preferred stock classes to compensate advisors and consultants while preserving cash, a common practice in the pre-revenue or early-growth stage biotech and technology sectors.

Comparison to Industry Standards

• The use of a $300,000 conversion value for advisory services is consistent with small-cap private-to-public transition strategies.
• The inclusion of a $1.00 floor price for conversion is a standard protective measure for investors in companies with high volatility or uncertain listing timelines.

Corporate Governance

Stakeholder Impact

• Existing common shareholders face potential dilution upon the conversion of the Series C Preferred Stock.
• Advisory partners gain a stake in the company's future equity performance.

Next Steps

• Monitor for potential listing applications on the Nasdaq or NYSE American before April 2027.
• Track any further issuance of the remaining three authorized shares of Series C Preferred Stock.

Key Dates

Keywords

Genvor Incorporated, Series C Preferred Stock, Equity Issuance, Advisory Agreement, Corporate Governance, Nevada Corporation